What Is CVS Fair Value?
CVS Health Corporation (CVS) fair value estimate using multiple valuation models, updated daily.
As of October 31, 2026, CVS Health Corporation (CVS) has a composite fair value estimate of $202.94 based on four valuation models: DCF (35% weight), Graham Number (25% weight), PEG (25% weight), and DDM (15% weight). The current market price is $90.25, suggesting the stock is undervalued by 124.9%.
Data as of October 31, 2026 (today)
Composite Fair Value
Undervalued4 of 4 models$202.94
vs. current price of $90.25(+124.9%)
How Is CVS Fair Value Calculated?
Four independent models estimate what CVS is worth. Each uses different inputs and assumptions. The composite blends them by weight.
CVS Intrinsic Value
Forward-looking models based on future cash flows
DCF (Discounted Cash Flow)
35% weightEstimates how much cash the company will generate over the next 10 years, then calculates what all that future cash is worth in today's dollars. Includes a 15% safety cushion. Try the standalone DCF calculator →
$296.11
+228.1%Undervalued
Inputs used
DDM (Dividend Discount Model)
15% weightIf a company pays you dividends, this model asks: how much are all those future dividend payments worth today? Only works for stocks that pay dividends. Try the intrinsic value calculator →
$193.64
+114.6%Undervalued
Inputs used
CVS Fair Value
Current fundamentals: earnings, assets, and growth rate
Graham Number (Value Investing)
25% weightCreated by legendary investor Benjamin Graham. It looks at two things: how much the company earns (EPS) and what its assets are worth (Book Value), then calculates the maximum price a careful investor should pay. Try the fair value calculator →
$106.23
+17.7%Undervalued
Inputs used
PEG (Price/Earnings to Growth)
25% weightChecks if you're paying a fair price for the company's growth. A fast-growing company deserves a higher price than a slow one. This model finds the right price based on how fast earnings are growing.
$101.62
+12.6%Fair Value
Inputs used
What If You Change the Assumptions?
Drag the sliders to test different scenarios. Tap the ? buttons to learn what each input means.
Your DCF Fair Value
Current price $90.25 is 228.1% below this estimate
View 10-year cash flow projections
| Year | Projected FCF (Free Cash Flow) | Present Value |
|---|---|---|
| Year 1 | $9.10B | $8.56B |
| Year 2 | $10.25B | $9.08B |
| Year 3 | $11.54B | $9.62B |
| Year 4 | $13.00B | $10.20B |
| Year 5 | $14.64B | $10.81B |
| Year 6 | $16.49B | $11.46B |
| Year 7 | $18.57B | $12.15B |
| Year 8 | $20.92B | $12.88B |
| Year 9 | $23.56B | $13.65B |
| Year 10 | $26.54B | $14.47B |
| Terminal Value | $724.60B | $395.02B |
What Are CVS's Key Financial Metrics?
Earnings & Growth
Current Price
$90.25
EPS (TTM)
$3.80
Forward P/E
10.6
Profit Margin
1.2%
Cash & Balance Sheet
Free Cash Flow
8.1B
EBITDA
16.7B
Book Value
$62.37
Total Debt
76.3B
What Do Analysts Say About CVS?
Low
$103.00
Average
$115.48
High
$145.00
Upside
+28.0%
CVS Fair Value FAQ
What is the fair value of CVS?
Based on our composite model (DCF 35%, Graham 25%, PEG 25%, DDM 15%), CVS's estimated fair value is $202.94. The stock is currently trading at $90.25, which makes it undervalued by our analysis.
How is CVS's fair value calculated?
We use four valuation methods: Discounted Cash Flow (DCF), Graham Number, PEG-based Fair Value, and Dividend Discount Model (for dividend-paying stocks). The composite score weights DCF at 35%, Graham and PEG at 25% each, and DDM at 15%. When a model can't be applied, its weight is redistributed proportionally.
Is CVS overvalued or undervalued?
Based on our analysis, CVS is undervalued. The current price of $90.25 is 124.9% below our estimated fair value of $202.94.
What do Wall Street analysts say about CVS?
25 analysts cover CVS Health Corporation with a consensus rating of "Strong Buy." The average price target is $115.48, ranging from $103.00 to $145.00. This implies 28.0% upside from the current price.